The "587" patent, I believe Gene was referencing claim # 6
Message 3309112
RT:
Check the detail of the HVSF patent claims. If you are heavily invested have a patent Atty give you an opinion don't trust me. Reference the "587" patent referred to here many times.
Gene Voss
4801587 : Impotence ointment
---------------------------------------------------------------------
INVENTORS: Voss; Gene, San Antonio, TX 78232
Eichler; Allen C., San Antonio, TX 78213
ASSIGNEES: none
ISSUED: Jan.ÿ31, 1989 ÿ FILED: Mar.ÿ2 , 1987
SERIAL NUMBER: 020544 ÿ MAINT. STATUS:
INTL.ÿCLASS (Ed.ÿ4): A61K 031/47; A61K 031/50;
U.S. CLASS: 514/248; 514/307; 514/400; 514/502; 514/649; 514/947;
FIELD OF SEARCH: 514-307,400,248,502,649 ;
12 CLAIMS
I claim:
ÿÿÿÿ1. A method of relieving impotence comprising the single step of applying an ointment to the skin around the penis, said ointment comprising:
a primary agent, being a vasodilator, selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine or phentolamine, said primary agent being present in said ointment in an amount between one and five percent by weight;
dimethyl sulfoxide for assisting absorption of said primary agent through said skin; and
a base.
ÿÿÿÿ2. The method of claim 1 wherein said ointment is applied to the glans portion of the penis.
ÿÿÿÿ3. A method of relieving impotence comprising the steps of:
applying a first ointment to the skin around the penis, said first ointment containing only a carrier for assisting absorption of a primary agent through said skin;
removing said first ointment from said skin after a short period of time; and
applying a second ointment to said skin said second ointment containing said primary agent, wherein said primary agent is selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine and phentolamine, and
said primary agent is present in said second ointment in an amount between one and five percent by weight.
ÿÿÿÿ4. The method of claim 3 wherein said carrier is dimethoxy sulfoxide.
ÿÿÿÿ5. The method of claim 3 wherein said first and second ointments are applied to the glans portion of said penis.
ÿÿÿÿ6. A method of relieving impotence comprising the steps of:
placing a catheter within the urethra of the penis, said catheter being in fluid communication with a tube, said tube containing an ointment, said ointment comprising a primary agent and a base, wherein said primary agent is a vasodilator and is present in an amount of between one and five percent by weight; and
squeezing said tube thereby extruding said ointment into said catheter and into said urethra.
ÿÿÿÿ7. The method of claim 6 wherein said primary agent is selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine and phentolamine.
ÿÿÿÿ8. The method of claim 6 wherein said ointment further comprises a carrier for assisting absorption of said primary agent through the wall of said urethra.
ÿÿÿÿ9. The method of claim 8 wherein said carrier is dimethoxy sulfoxide.
ÿÿÿÿ10. A method of relieving impotence comprising the steps of:
surgically removing a portion of the fibrous sheath surrounding the corpora cavernosa within the penis; and applying an ointment to the skin around said penis, said ointment comprising a primary agent, being a vasodilator, and a base, said primary agent being present in an amount of between one and five percent by weight.
ÿÿÿÿ11. The method of claim 10 wherein said primary agent is selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine and phentolamine.
ÿÿÿÿ12. The method of claim 10 wherein said ointment further comprises a carrier for missing absorption of said primary agent through the wall of said urethra.
---------------------------------------------------------------
Zebra |
